58 / 100

Dr. Sandy Tretbar | Nanoparticle encapsulation Award | Best Paper Award

Dr. Sandy Tretbar, Fraunhofer IZI, Germany

Sandy Tretbar, born on February 1, 1985, in Stollberg, Germany, is a distinguished biologist specializing in genetics. After completing her Biology studies at Martin Luther University in Halle-Wittenberg, she pursued a Ph.D. at the University of Leipzig, focusing on the function and evolution of bacterial tRNA nucleotidyltransferases. Following her doctoral studies, she conducted postdoctoral research at the University of Wisconsin-Madison, delving into biochemical and single molecule studies of yeast spliceosomal proteins. Tretbar’s research contributions extend to posttranscriptional regulation in renal cell carcinoma and immune tolerance at institutions like the Fraunhofer Institute for Cell Therapy and Immunology, Leipzig. She has garnered recognition for her work, including poster prizes and awards for outstanding presentations. Since 2022, Tretbar leads a working group at Fraunhofer IZI, Leipzig, focusing on the development of mRNA-based cell therapies. Fluent in English and German, she is also a member of esteemed scientific societies such as the RNA Society and the German Society for Gene Therapy.

Professional Profile:

Scopus

Orcid

šŸŽ“ Education:

Sandy Tretbar completed her Biology studies with a focus on Genetics at Martin Luther University in Halle-Wittenberg from 2003 to 2009. During this time, she developed a keen interest in molecular biology, particularly in the intricate mechanisms underlying genetic processes. Her academic journey continued with a Diploma thesis at the University of Leipzig, where she delved into the realm of tRNA editing in Saccharomyces cerevisiae from April 2008 to November 2008. This experience deepened her understanding of molecular genetics and paved the way for her subsequent research endeavors. Building upon her foundational knowledge, Sandy pursued a Ph.D. at the University of Leipzig from January 2009 to February 2013, focusing on bacterial tRNA nucleotidyltransferases. Throughout her academic pursuits, she demonstrated a remarkable dedication to unraveling the complexities of genetic regulation, showcasing her commitment to advancing the field of molecular biology.

šŸ”¬ Research Experience:

Following her Ph.D., Sandy Tretbar embarked on a postdoctoral position at the University of Wisconsin-Madison from March 2013 to February 2015. Here, she immersed herself in the study of yeast spliceosomal proteins, contributing to the advancement of understanding in this intricate field of molecular biology. Building on her postdoctoral experience, Sandy transitioned to a research assistant role at Martin Luther University Halle-Wittenberg, where she dedicated her efforts to investigating posttranscriptional regulation in renal cell carcinoma from August 2016 to June 2018. Her research during this period shed light on the molecular mechanisms underlying cancer progression, showcasing her versatility in tackling complex biological questions. Subsequently, Sandy assumed the role of a research associate at the Fraunhofer Institute for Cell Therapy and Immunology from July 2018 to December 2021, specializing in immune tolerance. Her contributions to the field were marked by innovative approaches and a profound commitment to improving therapeutic outcomes. Presently, Sandy serves as the Head of a working group at the Fraunhofer Institute, focusing on mRNA-based cell therapies since January 2022. In this leadership role, she continues to drive forward cutting-edge research aimed at harnessing the potential of mRNA technologies for cell-based therapeutic interventions.

šŸ† Awards and Organizations:

Throughout her career, Sandy Tretbar has garnered recognition for her contributions to the scientific community. Her research excellence has been acknowledged through multiple poster prizes at various conferences, highlighting her ability to effectively communicate complex scientific concepts. Additionally, she was honored with an award for Outstanding Oral Presentation, underscoring her talent for delivering impactful presentations that captivate audiences. Beyond accolades, Sandy is an active member of several esteemed scientific societies, including the RNA Society and the German Society for Gene Therapy. Her involvement in these organizations reflects her commitment to staying abreast of the latest developments in her field and engaging with peers to advance scientific knowledge collectively. Through her participation and achievements, Sandy continues to make significant contributions to the scientific community, shaping the future of molecular biology and genetic research.

Publication TopĀ  Notes:

  1. Ā Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering
    Published Year: 2023
    Journal: Molecular Therapy Methods and Clinical Development
    Cited By: 4 Citations
  2. Ā Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionality
    Published Year: 2023
    Journal: Scientific Reports
    Cited By: 1 Citation
  3. Ā Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids
    Published Year: 2022
    Journal: Molecules
    Cited By: 4 Citations
  4. Ā Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
    Published Year: 2021
    Journal: Frontiers in Immunology
    Cited By: 9 Citations
  5. Ā Chemical and Cytotoxic Activity of three main Sesquiterpenoids from Warburgia ugandensis
    Published Year: 2021
    Journal: Results in Chemistry
    Cited By: 4 Citations

 

 

 

Dr. Sandy Tretbar | Nanoparticle encapsulation Award | Best Paper Award

You May Also Like